II P > 0.3. ~1 P = 0.03.
are omitted for clarity. Ts2 induction was also assayed by transferring the washed cultured cells (4 × 106) into syngeneic recipients, which were then challenged i.p. with either 20 gg of GAT or 50 gg of GT as GT-MBSA in 0.2 ml of saline containing 5% Maalox and 109 B. pertussis organisms (Eli Lilly, Indianapolis, Ind.) as adjuvant. Specific PFC were determined 7 d later using GAT-SRBC. Data are reported as PFC/spleen ± SEM. All indicated differences are significant at the P < 0.05 level, using Student's t test. Table I confirm previous studies (31, 32) showing B6 and A/J mice to be GT nonsuppressors, but nonetheless to possess Is genes able to complement for suppression in (B6A)F1 animals. These findings, together with the information that A/J mice do not produce detectable GT-TsF, suggest that (B6A)F1 mice can produce and be suppressed by GT-TsF, and that either both A/J and B6 contribute genes, which are necessary for both TsF generation and activity, or that the B6 mouse can produce GT-TsF, but not be suppressed by it. In the FI, the two parts of the complete pathway would be brought together, yielding a suppressor animal. To test these hypotheses, extracts were prepared from spleens and thymuses of GT-primed A/J, B6, and (B6A)F1 mice from the same groups of animals used to check suppressor status, as reported in Table I . The activity of such extracts and control extracts from animals receiving Maalox alone, as assayed by direct suppression of GT-MBSA responses in vitro, is shown in Figs. 1 and 2 . Fig. 1 demonstrates that, as predicted, (B6A)Fx and B6 mice produce GT-TsF active on the GT-MBSA response of the suppressor strain BALB/c. However, as already demonstrated (37), A/J mice fail to yield active GT-TsF, as assayed on BALB/c cells. Although these cells should be appropriate targets for any GT-TsF produced by the A/J cells because no H-2 barriers to GT-TsF activity in suppressor strains are known to exist, and in particular, BALB/c GT-TsF is active in A/J mice, to verify the absence of GT-TsF in sonicates of GT-primed A/J cells, the F1 and A/J extracts were also retested on (B6A)Fx cells. Such Fx cells are the most likely candidate for an appropriate target for any cryptic A/J GT-TsF. As shown in Fig. 2 , the Fa GTTsF had the expected activity on Fx cells, but the A/J material was still devoid of suppressive potential. Although not shown, all factors presented in these figures and the experiments reported below were tested for nonspecific suppression of SRBC and/ or GAT responses, and shown to be specific for GT-MBSA responses.
Results

(B6A)Ft and B6, but Not A/J, Mice Produce Detectable GT-TsF. The data in
A/J, but Not B6, Mice Can Be Suppressed by GT-TsF, and Generate Active Ts~ upon TsF
Exposure. Earlier studies also demonstrated that A/J mice could be directly suppressed by GT-TsF from another strain, and yield Ts2 in vivo or in vitro when exposed to such GT-TsF (35, 36) . Table II shows that B6 mice, in contrast, cannot be suppressed directly in vitro by (B6A)F1 TsF. This defect is expected since in mice which produce GT-TsF, nonsuppressor status must result from a functional failure of TsF activity.
The ability of the nonsuppressor strain B6 to produce GT-TsF active in direct suppression of other strains raised the question of whether (a) this active extract also could cause Ts2 induction, and (b) if so, whether the defect in B6 mice responsible for their nonsuppressor status was the inability to generate functional suppression at the Ts2 or later stages in the pathway. It has already been shown that GAT-TsF fails to suppress directly GAT responder mice, but nonetheless can induce Ts2 which are active in such responder animals (40) . To explore these issues, in vitro generation of Ts2 was attempted using (B6A)F1 and B6 GT-TsF as well as extracts from GT-primed A/J mice. As shown in Fig. 3 , B6 GT-TsF, but not the A/J extract, could induce active Ts2 using A/J cells in vitro, which were able to suppress the GT-MBSA response of syngeneic A/J mice. Fig. 4 reveals, however, that although both B6 and (B6A)F] GT-TsF induce Ts2 using A/J spleen cells, neither suppressor factor preparation can cause B6 spleen cells to become active suppressors. These data indicate either a failure of GT-TsF to produce Tsz, or a failure of such Ts2 to be able to mediate suppression, in B6 mice. 
Specificity of the B6 D~ect in
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Failure of (B6A )F1 GT-TsF to Suppress Directly B6 GT-MBSA PFC Responses in Vitro
Responding spleen Antigen:]:
5/~g GT-MBSA + 370 0 * 7.5 × 106 cells/1 ml modified Mishell-Dutton culture. :~ 5 #g GT as GT-MBSA added per 1 ml culture. § -, no factor added; +, 1/900 final dilution of (B6A)FI GT-TsF in the culture. II Specific IgG PFC/eulture on day 5, assayed on GAT-SRBC. ¶ Compared with group without TsF.
immunity is typically a highly antigen-specific phenomenon (28), the specificity of the defect in TsF activity in B6 mice was investigated. As noted above, GAT responder mice can be suppressed by nonresponder-derived GAT-TsF if such TsF is first permitted to induce GAT-Ts2, either in vivo or in vitro (40) . Thus, the ability of B6 (GAT responder) mice to yield Ts2 active in suppressing GAT responses upon coculture with GAT-TsF was tested. SJL mice, which are suppressors for both GAT and GT, were used to prepare GAT-TsF and GT-TsF, to avoid any complicating effects caused by use of TsF derived from different strains of mice. B6 spleen cells were GT-TsF used was active, since it induced potent GT-Ts2 in A/J mice.
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H-2 Linkage of A/J and B6 Prototype Defects.
Over-all suppression induced by GT priming is clearly under H-2-1inked Is gene control (29) (30) (31) (32) . It was therefore expected that the selective defects in factor production and activity seen in A/J and B6 mice, respectively, would also be H-2 linked. A limited series of experiments has been performed to test this prediction. Extracts of spleen and thymus have been prepared from GT-primed B6 (H-2b), A.BY (H-2b), and B10.A (H-2 a) mice, and previously tested GT-TsF assayed on several of these same strains. As shown in Fig. 6 , both H-2 b strains B6 and A.BY produce active GT-TsF, while B10.A, an H-2 a strain, fails to 
SPECIFIC /gG PFC/CNLTURE
H-2-1inked control of GT-TsF activity. Same basic protocol as in Fig. 1 . Discussion The data presented above document that independent antigen-specific H-2-1inked genetic lesions can affect two previously defined steps in suppressor T cell pathways. Thus, H-2" animals fail to produce detectable GT-TsF when challenged with GT. Nevertheless, such H-2 a animals possess cells able to mature into active Ts2, when exposed to active GT-TsF from any of several allogeneic sources. Conversely, H-2 b mice produce GT-TsF after GT priming, but neither this factor nor that from other strains, can cause suppression of H-2 b responses to GT-MBSA. Either defect (lack of TsF production or failure of TsF action) is sufficient to render the animal phenotypically a GT nonsuppressor. Combination of H-2" and H-2 b genomes in the form of F1 mice such as (B6A)F1 is sufficient to restore the ability to demonstrate GT suppression, involving GT-TsF generation and activity.
TABLE III
H-2 Control of Direct Suppression Mediated by GT-TsF
Several other groups have reported isolated genetic defects in either T suppressor factor production or activity, but these observations appear to differ from those described above. Thus, Taniguchi et al. (41) have shown that A/J mice fail to produce keyhole limpet hemocyanin (KLH)-TsF, but can be suppressed by KLH-TsF from other I-J k mice. In the same model all B10 congenic mice produce KLH-TsF but fail to be suppressed by any I-J matched KLH-TsF. Although these defects resemble those reported here, Taniguchi et al. found that these KLH-related defects are not linked to H-2, but rather to background genes. In addition, B6 mice can be suppressed by KLH-TsF, in contrast to GT-TsF. It should also be noted that A/J mice have been shown to produce TsF active in some humoral (42) and cell-mediated (43) immune responses, indicating that the defects for KLH and GT do not reflect a general lesion at this level in these mice. Rich et al. (44) have demonstrated a failure of B6 mice to produce a suppressor factor active in decreasing mixed lymphocyte responses (MLR). These mice possess the structural gene for MLR-TsF, however, because F1 mice between B6 and BALB/c yield TsF showing an I-C restriction for activity in the nonproducer strain. It remains to be seen how these similar but genetically distinct defects relate to one another.
The findings reported in this paper have particular significance for two aspects of suppressor cell function. First, by documenting a genetic basis for the previously proposed Tsl ~ Ts2 model of Ts function, they strengthen the concept of suppression as the end result of a series ofT-T interactions involving distinct T cell subsets. Such T cell circuits have been described by several groups. In the GT and GAT models, it was first reported that TsF acted by inducing Ts2, in vivo or in vitro, even in animals phenotypically nonsuppressor by virtue of a defect in TsF production (35, 36, 39, 40, 45, 46) . This further agreed with the finding that suppressor mice, treated with cyclophosphamide, failed to produce GT-TsF but nonetheless could be suppressed by such suppressor material, suggesting two distinct T cell populations, differing in cyclophosphamide sensitivity, involved in suppression (47) . Tada has reported almost identical findings for KLH-TsF (48) . The target of this factor is a KLH-primed Ly 123 + T cell which adheres to nylon wool, in contrast to the Ly 23 + nylon nonadherent TsF producer. In both models, Ts2 induction requires both I-J determinant-bearing factor and specific antigen. The ability of TsF to induce new (Ts2) suppressors has also been demonstrated for tumor-sPecific antigens (49) , and for haptens using delayed type hypersensitivity models (50) . Finally, the feedback suppression loop described by Eardley et al. (51) in the response to SRBC also involves T-T interactions which are apparently mediated by TsF (52) . Thus, the GT model serves as a prototype of a generalizable model for T cell suppression, in which mice with distinct lesions in each step can serve as unique tools for studying selectively the origin of the defect and thus, the normal mechanism of Ts activation.
This last point relates directly to the issue of I region gene involvement in Ts activity. Previous studies have revealed that GT suppression is controlled by at least two complementing genes located in the I-A and I-C subregions of H-2 (32). These subregions do not appear to contain structural genes for GT-TsF, a function ascribed to a third gene located in the I-J subregion (34) . It is therefore necessary to consider other possible ways in which I-A and I-C genes might control Ts activity in an antigen-specific manner. To us, the most likely hypothesis is that, in analogy with other T cell subsets, these genes produce cell surface glycoproteins involved in "antigen presentation." BALB/c (I-A d, I-C a) mice and B10.BR (I-A k, I-C k) mice each can produce and be suppressed by GT-TsF (33) . Furthermore, B 10.BR GT-TsF is active in BALB/c mice, and BALB/c GT-TsF is active in both B10.BR and A/J mice (37) . Therefore, it appears that the defect in A/J (I-A k, I-C a) mice for production of GTTsF cannot be ascribed to a problem with either oneor the other Is gene, but must be due to a failure of the two genes to interact appropriately for the postulated presentation function (i.e., this system shows coupled complementation [53] ). Thus, in a suppressor system Is control of GT-triggering of Tsl for TsF production would be analogous to Ir gene control of Tn activation for the terpolymer L-glutamic acid-Llysine-L-phenylalanine (53, 54) . Such a model leads to several testable predictions. First, in the complementing Fa (B6 × A), successful GT presentation should elicit both I-J b and I-J k determinant-bearing TsF, since the postulated defect in A/J is not in a locus affecting TsF structure per se. For the same reason, the TsF produced by the suppressor B10.A(5R) strain which has its I-J subregion derived from the H-2" haplotype, should also be bound by anti-I-J k alloantibodies. Second, in the same (B6A)F1, presentation of GT on parental cells should fail to evoke Tsl activity, whereas GT on B6 cells should trigger TsF formation. The identity of the hypothetical "presenting" cell is totally unknown, but is likely to be a subpopulation of either macrophages or T cells. Furthermore, the relevant Ia molecule involved in this presentation activity need not be the same as that found on conventional antigen presenting cells or B cells. In fact, such a notion is given support by the occurrence of Tsl activity in H-2 b and H-2 s mice, which lack serologically detectable E/C products (54), as well as the fact that macrophage and B cell Ia appears to be a product of I-A and I-E, not I-C, genes.
As concerns Is regulation of TsF function, exemplified by the defect in H-2 b mice, a similar model involving I-A:C control of TsF presentation may be postulated. Recent studies have indicated that TsF molecules bear idiotypic determinants shared with antibody of the same antigen specificity, particularly in systems with common cross-reactive idiotypes (55, 56) . Although T cell-mediated suppression is antigen specific, in these cases, idiotype-specific effects will appear antigen specific. Thus, triggering Ts2 by idiotype-bearing TsF would involve the activation of suppressor cells with anti-idiotypic specificity, as proposed previously by Singer and Williams (57) . We have recently found that Ts2 induced by azobenzenearsonate-specific TsF in A/J mice can be bound selectively to plastic plates coated with antiarsonate antibodies bearing idiotypic determinants shared with the TsF used to induce the Ts2, thus confirming this prediction in at least one experimental system (50) . Similarly, Eardley et al. have shown variable portion of the Ig heavy chain (VH) restriction of T-T interactions in the feedback suppression loop (58) . Ts2 triggering in many cases may therefore involve the activation of anti-idiotypic cells recognizing the idiotype of TsF, perhaps in the form of idiotype-antigen complexes, since antigen is critical for Ts~ triggering (39) . Such recognition may require TsF presentation in the context of H-2 products, and therefore, the potential for Ir gene regulation. Thus, the failure of GTTsF to cause Ts2 activation may derive from failure of certain I-A:C gene products to mediate effective GT-TsF idiotype presentation to Ts2 cells. An alternative explanation for the data is that the control of TsF activity resides in I-A:C-coded acceptor molecules on precursors of Ts2. In this case, to account for the antigen specificity of the defect in H-2 b mice, one would have to postulate that the I-A:C-coded acceptors are restricted with respect to the specificity of the TsF they can recognize due to selective V-C (Vn:I-J) association in factor formation (see Munro and Taussig [59] for details).
Finally, it should be noted that the accumulating data in the GT model, together with information derived from studies of many other investigators, strongly suggest that over-all immune regulation cannot be neatly divided into major histocompatibility complex vs. idiotype directed pathways. In particular, H-2-1inked Ir genes may play a major role in controlling auto-anti-idiotypic responses. Thus, the products and activities of these two multigene clusters seem to be intimately interrelated in the activities of the complex networks that constitute the immune system.
Summary
The occurrence of distinct genetic defects affecting the generation of T cell-derived suppressor factor (TsF) or the suppressive activity of such TsF was investigated. For the synthetic polypeptide L-glutamic acidS°-L-tyrosine 5° (GT), it could be shown that the nonsuppressor strain A/J fails to produce suppressor T cells (Tsa) capable of GTTsF generation upon challenge with GT. Conversely, B6, another nonsuppressor strain, produces GT-TsF active on other allogeneic strains such as A/J, but itself fails to be suppressed by this material. (B6A)F1 mice both make GT-TsF, and are suppressed by it. Further experiments revealed that the production of GT-TsF and the ability to be suppressed by GT-TsF are under the control of H-2-1inked genes. Finally, the defect in GT-TsF activity in B6 mice was shown to be exquisitely antigen specific, in that this strain can be suppressed by a closely related TsF specific for Lglutamic acid6°-L-alanine3°-L-tyrosine 1°. It is suggested that H-2 (I) control of suppressor T cell (Ts) activity may reflect the involvement of I-A and I-C gene products in antigen presentation to Ts in analogy with other T cell subsets, and that TsF function might also involve such presentation, in this case of the idiotypic structures of the TsF-combining site. Predictions deriving from this hypothesis are discussed, including the possibility that H-2 linked immune response genes regulate auto-antiidiotypic responses in immune networks.
